Omslagsbild

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan

COVID-19 pandemic has severely affected Pakistan with 1,557,134 cases as of August 4, 2022. However, the data regarding breakthrough infections in Pakistan is scant. Hence, the objective was to analyze SARS-CoV-2 breakthrough infections with respect to vaccines and variants during the fifth wave in...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsmän:	Zunera Jamal (Författare, medförfattare), Murtaza Haider (Författare, medförfattare), Aamer Ikram (Författare, medförfattare), Muhammad Salman (Författare, medförfattare), Muhammad Suleman Rana (Författare, medförfattare), Zaira Rehman (Författare, medförfattare), Syed Adnan Haider (Författare, medförfattare), Muhammad Ammar (Författare, medförfattare), Nadia Nisar (Författare, medförfattare), Massab Umair (Författare, medförfattare)
Materialtyp:	Bok
Publicerad:	Frontiers Media S.A., 2022-09-01T00:00:00Z.
Ämnen:	article
Länkar:	Connect to this object online.
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Liknande verk

The world's largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
av: Muhammad Suleman Rana, et al.
Publicerad: (2022)

Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account
av: Massab Umair, et al.
Publicerad: (2021)

Genetic diversity and phylogenetic analysis of Crimean-Congo Hemorrhagic Fever viruses circulating in Pakistan during 2019.
av: Massab Umair, et al.
Publicerad: (2020)

Insights into measles virus: Serological surveillance and molecular characterization
av: Zainab Khalid, et al.
Publicerad: (2024)

Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
av: Fridah Mwendwa, et al.
Publicerad: (2024)

Outcomes of Monoclonal Antibody Infusion Treatment During Delta (B.1.617.2) and Omicron (B.1.1.529) COVID 19 Variant Surges among Vaccinated and Unvaccinated Patients
av: Haider Ghazanfar, et al.
Publicerad: (2022)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
av: Wanting Li, et al.
Publicerad: (2023)

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection
av: Jin-Jin Chen, et al.
Publicerad: (2023)

An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA
av: Mohammad Tabatabai, et al.
Publicerad: (2023)

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
av: Pradipta Paul, et al.
Publicerad: (2023)

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
av: Tananya Lokanuwatsatien, et al.
Publicerad: (2023)

Identification of measles virus genotype B3 associated with outbreaks in Islamabad, Pakistan, 2013-2015
av: Syed S.Z. Zaidi, et al.
Publicerad: (2018)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
av: Yayun Liu, et al.
Publicerad: (2023)

Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates
av: Alexander L Lundberg, et al.
Publicerad: (2022)

Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway
av: Arild Iversen, et al.
Publicerad: (2024)

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
av: Andrea Mella-Torres, et al.
Publicerad: (2022)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
av: A Reum Kim, et al.
Publicerad: (2023)

COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles
av: Alberto Corriero, et al.
Publicerad: (2022)

Epidemiological trend of chikungunya outbreak in Pakistan: 2016-2018.
av: Nazish Badar, et al.
Publicerad: (2019)

Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort studyResearch in context
av: Anis Karuniawati, et al.
Publicerad: (2024)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
av: Nawfal R. Hussein, et al.
Publicerad: (2022)

Breakthrough infection with SARS-CoV-2 delta variant in old-age homes in a Southern District of Kerala, India
av: Dhanusha Chandran, et al.
Publicerad: (2022)

Assessing the impact of Delta and Omicron in German intensive care units: a retrospective, nationwide multistate analysis
av: Matthäus Lottes, et al.
Publicerad: (2024)

A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
av: Laura Peyton Ellis, et al.
Publicerad: (2023)

Prevalence of dengue virus in Haripur district, Khyber Pakhtunkhwa, Pakistan
av: Humera Qureshi, et al.
Publicerad: (2023)

Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
av: Qidong Hu, et al.
Publicerad: (2022)

Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
av: Gunadi, et al.
Publicerad: (2023)

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
av: Chad D. Fibke, et al.
Publicerad: (2022)

Third wave COVID-19 delta variant breakthrough infection in a Hispanic-dominant suburb of Miami, Florida: ethical dilemma and vaccination hesitancy
av: Sam Kara, et al.
Publicerad: (2022)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
av: Chengzhuo Tong, et al.
Publicerad: (2022)

Severe COVID-19 outcomes in pediatrics: An observational cohort analysis comparing Alpha, Delta, and Omicron variantsResearch in context
av: Amit Bahl, et al.
Publicerad: (2023)

Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2
av: Ly Hien Doan, et al.
Publicerad: (2022)

Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study
av: Andrew C Steer, et al.
Publicerad: (2023)

Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial
av: Muhammad Amjad Pervez, et al.
Publicerad: (2022)

Breakthroughs in Melanoma Research
Publicerad: (2011)

Actionable wastewater surveillance: application to a university residence hall during the transition between Delta and Omicron resurgences of COVID-19
av: Ryland Corchis-Scott, et al.
Publicerad: (2023)

Clinical characteristics and severity markers in hospitalized COVID-19 patients from western Mexico: a comparative analysis of Delta and Omicron variants
av: Hazael Ramiro Ceja-Gálvez, et al.
Publicerad: (2024)

Outcomes of patients hospitalized for COVID-19, secondary infections, antimicrobial use during SARS-CoV-2 delta and omicron variants
av: Swetha Srialluri, et al.
Publicerad: (2023)

Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
av: Lenin Domínguez-Ramírez, et al.
Publicerad: (2022)

Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital
av: D. Obeid, et al.
Publicerad: (2023)